Thiopental, powder/lyophilisate, 1 g, Propofol, emulsion, 10 mg/ml, 20 ml, Suxamethonium, solution for injection, 20 mg/ml, 5 ml, Atracurium, solution for injection, 10 mg/ml, 5 ml

This tender concerns the procurement of several essential pharmaceutical products, including Thiopental (powder/lyophilisate, 1g), Propofol (emulsion, 10 mg/ml, 20 ml), Suxamethonium (solution for injection, 20 mg/ml, 5 ml), and Atracurium (solution for injection, 10 mg/ml, 5 ml). These medications are typically used in anesthesia and intensive care settings. The items are classified under CPV codes 33660000-4 (Medicinal products for the treatment of nervous system and sense organ disorders) and 33630000-5 (Medicinal products for the treatment of dermatological diseases and musculoskeletal disorders). The tender aims to ensure the availability of these critical drugs for medical procedures and patient care. Specific details regarding quantities, delivery schedules, and the exact procuring entity are not fully provided in the excerpt but the nature of the items suggests a healthcare provider or a central medical supply agency.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 72,619.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.